Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers

Cancer-specific targeting sparing normal tissues would significantly enhance cancer therapy outcomes and reduce cancer-related mortality. One approach is to target receptors or molecules that are specifically expressed on cancer cells. Peptides as cancer-specific targeting agents offer advantages su...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Nucl Med
Main Authors: Kapoor, Vaishali, Dadey, David Y.A., Nguyen, Kim, Wildman, Scott A., Hoye, Kelly, Khudanyan, Arpine, Bandara, Nilantha, Rogers, Buck E., Thotala, Dinesh, Hallahan, Dennis E.
Formato: Artigo
Idioma:Inglês
Publicado: Society of Nuclear Medicine 2016
Assuntos:
Basic Science Investigations
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5126697/
https://ncbi.nlm.nih.gov/pubmed/27445290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.115.165118
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares